← Journeys Incubator MODERATE Startup
Programme Research
Journeys Incubator ·
Programme Site
MEDIUM confidence Researched 2026-08-04 20:37 · profile: startup
Journeys Incubator is a four-month, mentor-driven programme by the University of Helsinki that supports early-stage ventures tackling societal 'wicked problems' across sustainability, social impact, and deep tech. It exists to help founders refine their ideas, build scalable startups, and connect with investors and corporate partners, with a strong emphasis on hands-on learning and global growth.
- Open to all residents of Helsinki Capital Region (no University of Helsinki affiliation required) - Teams with strong commitment, dedication, and excellent ideas - Early-stage ventures (no significant existing turnover; registered companies allowed but not advised) - Fit with one of the three tracks: Sustainability, Social Impact, or Deep Tech (AI/ML, robotics, quantum, synthetic biology, etc.) - Potential to build a scalable startup and attract funding - Willingness to commit to mandatory in-person sessions and bi-monthly mentoring - Application materials: pitch deck, video, and other standard startup application components (as per Dealum form)
The page does not list specific past winners, but the programme targets early-stage founders from diverse fields, including researchers, students, and professionals. Typical cohorts include ventures in agritech, clean energy, health-tech, and AI-driven solutions, with a mix of sustainability and deep tech projects.
The ideal applicant is a highly motivated early-stage founder (or small team) with a science-based or tech-driven venture that addresses a pressing societal challenge. They have a validated proof-of-concept, a clear vision for scalability, and are eager to engage with mentors, refine their business model, and prepare for fundraising. They are based in the Helsinki Capital Region and can commit to the intensive 16-week programme.
For Eniola Olutogun, the strongest angle is the deep tech track, specifically the AI/ML and synthetic biology intersection. The venture's use of protein language models to predict drug resistance mutations directly aligns with the programme's focus on advanced technologies grounded in science. Eniola should frame the venture as a scalable, AI-driven drug discovery platform with global health impact, leveraging her unique pharmacist-ML engineer background and the validated AUROC performance to demonstrate technical credibility and commercial potential.
Geographic eligibility is a major hurdle: the programme is open only to residents of the Helsinki Capital Region. Eniola is based in France (Paris area), so unless she can relocate or establish residency in Helsinki, she is not eligible. Additionally, the programme requires mandatory in-person attendance, which would be challenging for a non-local founder. The venture is not yet incorporated, which is acceptable but may be a minor disadvantage compared to teams with a registered entity.
2026-08-04 19:59 · high confidence
2026-07-30 08:59 · high confidence